Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.

@article{Nrgaard2017PsychotropicPI,
  title={Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.},
  author={Ane N\orgaard and Christina Jensen-Dahm and Christiane Gasse and Elsebet Steno Hansen and Gunhild Waldemar},
  journal={Journal of Alzheimer's disease : JAD},
  year={2017},
  volume={56 2},
  pages={
          707-716
        }
}
BACKGROUND Antipsychotics and other psychotropics are frequently used to treat neuropsychiatric symptoms in patients with dementia, even though the evidence for effect is limited. Concerns have been raised about the safety of antipsychotics, but concomitant use of multiple psychotropic drug classes (psychotropic polypharmacy) may also pose a risk for patients. OBJECTIVE To investigate the prevalence and predictors associated with use of psychotropic polypharmacy in patients with dementia… CONTINUE READING